Clinical Trial

Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Previous clinical observations of potential benefit from Roxadustat in this complex patient population prompted this investigation Therefore, the investigators designed this retrospective, observational study to thoroughly investigate the effects of Roxadustat on heart failure treatment and ventricular remodelling in this specific patient population, aiming to provide new insights for patients management.
Trial Details
NCT Number NCT07268807
Lead Sponsor Zhongda Hospital
Conditions Heart Failure, CKD, Anemia
Enrollment 200 participants
Start Date 2025-12-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-08